CH-4630808

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCH-4630808
Drug Alias NameCH 4630808NA 808NA-808
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus replication inhibitorsSerine C-Palmitoyltransferase inhibitors
TargetsSerine C-Palmitoyltransferase
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChugai Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A